Article

Japan

Roche Diagnostics Japan

Present since 1932 | 12.8% market share in in-vitro diagnostics

From 2018 – 2019

64 diagnostic solutions received approval | 58 diagnostic solutions secured public reimbursements

The Healthcare Landscape in Japan 

Japan is home to 126 million people, all of whom are covered by the country’s public health insurance. The scheme covers 70% of medical costs to ensure healthcare is accessible for all citizens. To cope with the greying population, Japan adopted a decentralised care system where regional governments manage their own healthcare plans.

Our commitment to Sustainability in Japan

  • Access to healthcare and diagnostics: In Japan, our efforts are focused on ensuring sustainable funding solutions and improving disease awareness.
    • Driving awareness: Since 2009, we have been working closely with experts to educate women between the ages of 20 and 50 years old on cervical cancer prevention and screening through a website. We also have long-standing partnerships with healthcare professionals to educate young people on sexually transmitted infections (STIs) through our informative website.
    • Sustainable funding solutions: In 2018, we secured regulatory and reimbursement approval for our vitamin D assessment, the first of its kind in Japan. The public reimbursement of the test is an important milestone in the country’s efforts to boost its equity of care.
  • Fostering a great workplace:  We promote a sustained work-life balance and advance the health and wellbeing of our people. We offer employee subsidies for our diagnostic tests to encourage early screening. Male employees are entitled to paternal leave benefits.
  • Supporting communities: Since 2013, we have been providing on-site support for health check programs conducted in earthquake-affected areas in Iwate prefecture. Organised annually by Iwate Economy Class Syndrome Prevention Support Group and Morioka Municipal Hospital, the initiative utilises our diagnostic solutions for disease screening activities. Between 2016 to 2017, 861 residents were screened for deep vein thrombosis, out of which 102 were diagnosed. This is one of the many initiative Roche conducts in Japan. 
  • Minimising our environmental footprint: One of our key initiatives is to replace our company cars with energy-efficient hybrid cars. Between 2010 and 2018, we increased the number of hybrid vehicles by 195 which resulted in a significant decrease in carbon dioxide (CO2) emissions during the same period.